et al. Abstract 1281O: Atezolizumab vs platinum-based chemotherapy in blood-based tumour mutational burden–positive NSCLC: results of the blood first assay screening trial (BFAST) phase 3 Cohort C. Ann. Oncol. 32, S950–S951 (2021). Article Google Scholar Sholl, L. M. et al. The ...
B. et al. Stool DNA testing for the detection of pancreatic cancer: assessment of methylation marker candidates. Cancer 118, 2623–2631 (2012). Article CAS Google Scholar van Dam, L. et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood ...
Easily Available Blood Test Neutrophil-To-Lymphocyte Ratio Predicts Progression in High-Risk Non-Muscle Invasive Bladder CancerIntroduction: The inflammatory response surrounding the tumour has a major importance in the oncologic outcome of bladder cancers. One marker proved to be useful and accessible ...
Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells. Br J Cancer, 86 (1): 110-... DC Mou,SL Cai,...
Key Words HPV16 Antibodies Tumour marker Screening Blood test HNSCC Sorry, something went wrong. Please try again and make sure cookies are enabledReferences [1] E.M. de Villiers, C. Fauquet, T.R. Broker, H.U. Bernard, H zur Hausen Classification of papillomaviruses Virology, 324 (2004),...
Technetium-99m HL91 uptake as a tumour hypoxia marker: relationship to tumour blood flow. Technetium-99m HL91 (HL91) is a potential agent for imaging hypoxic tissue in vivo. To elucidate the relationship between hypoxia and blood flow in a tumou... M Tatsumi,K Yutani,H Kusuoka,... -...
Next, we examined a marker of DNA double-strand breaks, phosphorylated histone γ-H2AX present in leptonema to pachynema phases of the first meiotic division. Phosphorylated histone γ-H2AX densely stains the condensed X and Y chromosomes that form the sex body as a disruption of the XY body...
liquid biopsy test that determines the mutational status of the epidermal growth factor receptor (EGFR) gene was used to guide the response ofEGFRtyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) patients, which was approved by the FDA in clinical practice (Kwapisz,2017). Another...
d, Final heatmap demonstrating marker expression used to define cell populations. e, Manual gating of CD3-CD8A-CD45+CD56+ NK cells in adjacent/normal and PDA tissue samples, n=5 adjacent/normal tissue samples and n=4 PDA tissue samples. Two-sided Student’s t-test was performed to ...
In the present study, we tested the tumour-specific MAGE-1 and MAGE-3 transcripts in the peripheral blood of HCC patients by nested RT–PCR to detect the circulating tumour cells and evaluate their potential clinical implication. Of 30 HCC patients, the positive rate of MAGE-1 and MAGE-3 ...